Status Epilepticus Treatment Market Overview
Status Epilepticus is a medical emergency that starts when a seizure hits the 5-minute mark. Status epilepticus can have long-term consequences such as neuronal injury, alteration of neuronal networks and neuronal death. Status epilepticus is mainly of two type, Convulsive and non- Convulsive. Convulsive is a more common type of status Epilepticus.
It occurs when a person has prolonged repeated tonic-clonic seizures. Whereas, non-convulsive Status epilepticus occur when a person has long or repeated absence seizure. Therefore, due to long absence seizure, non-convulsive is expected to increase the demand for Status Epilepticus Treatment.
According to the Epilepsy Foundation, only about 25 percent of people who have Status Epilepticus will have Epilepsy and also most of the cases happens to children under the age of 15 and to adult who are more than 40 years. These, in turn, expected to increase the demand for Status Epilepticus Treatment.
Status Epilepticus Treatment Market: Drivers and Restraints
Increase in incidence of neurological disorder and high prevalence of epilepsy are expected to increase the demand for Status Epilepticus Treatment. According to the WHO, Status Epilepticus is a chronic non-communicable disease of the central nervous system, affection more than 50 million people globally. Further, due to abnormal activity of brain, which results in recurrent of seizure.
These seizure cause loss of balder function and other consequences and this is expected to increase the growth of Status Epilepticus Treatment Market.
On the other hand, there are many treatments for Status Epilepticus such as medication or sometimes surgery can control seizure in people. In addition, anti- epilepticus is used to control the seizure and also benzodiazepines are the standard of care for emergency treatment of status epilepticus.
Thus, these are anticipated to increase the growth of Status Epilepticus Treatment Market. Furthermore, acceptance of novel medications and upcoming epilepsy therapeutics are anticipated to boost the global Status Epilepticus Treatment market.
Status Epilepticus Treatment Market: Overview
The global Status Epilepticus Treatment market is segmented on the basis of type, end use and regions. On the basis of type, non-convulsive Status Epilepticus is expected to increase the demand for Status Epilepticus Treatment Market is due to long or repeated seizures which are harder to recognize as compared to Convulsive Status Epilepticus in which a person may be confused or unaware of anything.
Further, on the basis of end user, hospitals are anticipated to increase the growth of Status Epilepticus Treatment Market due to better healthcare facilities.
Status Epilepticus Treatment Market: Regional Overview
North America will show the high revenue for the Status Epilepticus Treatment market, due to high prevalence of disorder and the treatment options in the region followed by Europe. Further, collaboration among local manufacture will help to increase the market penetration of Status Epilepticus drugs in Latin America.
After North America, the Europe region will show the robust growth for the Status Epilepticus Treatment market in the near future, due to availability of drugs and better hospital infrastructure. The Middle East and Africa are expected to be least lucrative region for Status Epilepticus Treatment market due to lack of awareness about the Status Epilepticus Treatment.
Status Epilepticus Treatment Market: Key Players
The global Status Epilepticus Treatment market is consolidated, with several companies accounting for a major share of the market. Key players include SAGE Therapeutics, Marinus Pharmaceuticals, H.Lundbeck, CURx Pharmaceuticals and others.
The research report on Status Epilepticus Treatment market presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data.
It also contains projections using a suitable set of assumptions and methodologies. The research report on Status Epilepticus Treatment market provides analysis and information according to market segments such as geographies, application, and industry.
The report covers exhaust analysis on Status Epilepticus Treatment Market:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
Report on Status Epilepticus Treatment Market includes regional analysis
- North America (U.S., Canada)
- Latin America (Mexico, Brazil)
- Europe (Germany, Italy, France, U.K, Spain, Russia)
- East Asia (China, Japan, South Korea)
- South Asia (India, ASEAN)
- Oceania (Australia, New Zealand)
- Middle East and Africa (GCC Countries, South Africa, Northern Africa)
The report on Status Epilepticus Treatment market is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Status Epilepticus Treatment Market: Segmentation
The global Status Epilepticus Treatment market is classified on the basis of type, application, end user and region.
Based on Type, Status Epilepticus Treatment market is segmented into the following:
- Convulsive Status Epilepticus
- Non-convulsive Status Epilepticus
Based on Distribution Channel, Status Epilepticus Treatment market is segmented into the following:
- Ambulatory Surgical centers
- Homecare Settings